XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Bausch Health Companies Inc. Shareholders' (Deficit) Equity
Bausch Health Companies Inc. Shareholders' (Deficit) Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2019         352,600,000          
Beginning Balance at Dec. 31, 2019 $ 1,136 $ (1) $ 1,063 $ (1) $ 10,172 $ 429 $ (7,452) $ (1) $ (2,086) $ 73
Increase (Decrease) in Shareholders' Equity                    
Common shares issued under share-based compensation plans (in shares)         2,000,000.0          
Common shares issued under share-based compensation plans 1   1   $ 37 (36)        
Share-based compensation 27   27     27        
Employee withholding taxes related to share-based awards (24)   (24)     (24)        
Net (loss) income (152)   (152)       (152)      
Other comprehensive loss (197)   (195)           (195) (2)
Ending Balance (in shares) at Mar. 31, 2020         354,600,000          
Ending Balance at Mar. 31, 2020 $ 790   719   $ 10,209 396 (7,605)   (2,281) 71
Beginning Balance (in shares) at Dec. 31, 2020 355,422,347       355,400,000          
Beginning Balance at Dec. 31, 2020 $ 605   535   $ 10,227 454 (8,013)   (2,133) 70
Increase (Decrease) in Shareholders' Equity                    
Common shares issued under share-based compensation plans (in shares)         2,700,000          
Common shares issued under share-based compensation plans 11   11   $ 62 (51)        
Share-based compensation 31   31     31        
Employee withholding taxes related to share-based awards (41)   (41)     (41)        
Net (loss) income (607)   (610)       (610)     3
Other comprehensive loss $ (123)   (123)           (123)  
Ending Balance (in shares) at Mar. 31, 2021 358,104,438       358,100,000          
Ending Balance at Mar. 31, 2021 $ (124)   $ (197)   $ 10,289 $ 393 $ (8,623)   $ (2,256) $ 73